Cardiac involvement in scleroderma

Rheumatic Disease Clinics of North America

Volumn 22, Issue 4, 1996, Pages 841-860

  Deswal, A ^a   Follansbee, W P ^a  

^a A 382 Scaife Hall   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CORONARY BLOOD VESSEL; HEART ARRHYTHMIA; HEART CONDUCTION; HEART DISEASE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HUMAN; KIDNEY DISEASE; MYOSITIS; PERICARDIAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCLERODERMA; SYMPTOM; VALVULAR HEART DISEASE;

EID: 0029905888     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70304-5     Document Type: Article

References (87)

1. A. Akesson F.A. Wollheim Organ manifestations in 100 patients with progressive systemic sclerosis: A comparison between the CREST syndrome and diffuse scleroderma Br J Rheumatol 28 1989 281
2. E.L. Alexander G.S. Firestein J.L. Weiss Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis Ann Intern Med 105 1986 661
3. G.E. Brown P.A. O'Leary Skin capillaries in scleroderma Arch Intern Med 36 1925 73
4. B.H. Bulkley P.G. Klacsmann G.M. Hutchins Angina pectoris, myocardial infarction, and sudden cardiac death with normal coronary arteries: A clinicopathologic study of nine patients with progressive systemic sclerosis Am Heart J 95 1978 563
5. B.H. Bulkley R.L. Ridolfi W.R. Salyer Myocardial lesions of progressive systemic sclerosis: A cause of cardiac dysfunction Circulation 53 1976 483
6. S. Carette J. Turcotte G. Mathon Severe myositis and myocarditis in progressive systemic sclerosis J Rheumatol 12 1985 997
7. P.J. Chapman M.D. Pascoe R. Van Zyl-Smit Successful use of captopril in the treatment of “scleroderma renal crisis.” Clin Nephrol 26 1986 106
8. P.J. Clements D.E. Furst W. Cabeen The relationship of arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS) Am J Med 71 1981 38
9. P.J. Clements P.A. Lachenbruch D.E. Furst Cardiac score: A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis Arthritis Rheum 34 1991 1371
10. J.D. Coffman D.L. Clement M.A. Creager International study of ketanserin in Raynaud's phenomenon Am J Med 87 1989 264
11. H.T. Colfer S.K. Das L. Dabich Effect of cold stress on coronary sinus blood flow in patients with scleroderma J Assoc Acad Minor Phys 4 1993 62
12. S.M. Comens M.A. Alpert G.C. Sharp Frequency of mitral valve prolapse in systemic lupus erythematosus, progressive systemic sclerosis, and mixed connective tissue disease Am J Cardiol 63 1989 369
13. W.A. D'Angelo J.F. Fries A.T. Masi Pathologic observations in systemic sclerosis (scleroderma): A study of 58 autopsy cases and 58 matched controls Am J Med 46 1969 428
14. P.C. Dau M.B. Kahaleh R.W. Sagabiel Plasmapheresis and immunosuppressive drug therapy in scleroderma Arthritis Rheum 24 1981 1128
15. D.S. Dymond J.L. Caplin W. Flatman Temporal evolution of changes in left ventricular function induced by cold pressor stimulation. An assessment with radionuclide angiography and gold 195m Br Heart J 51 1984 557
16. R.J. Eason P.L. Tan P.J. Gow Progressive systemic sclerosis in Auckland: A ten-year review with emphasis on prognostic features Aust N Z J Med 11 1981 657
17. D.S. Echt R.R. Liebson L.B. Mitchell Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial N Engl J Med 324 1991 781
18. W.W. Ellis A.N. Baer R.M. Robertson Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis Am J Med 80 1986 385
19. M. Engelhart Ketanserin in the treatment of Raynaud's phenomenon associated with generalized scleroderma Br J Dermatol 119 1988 751
20. C. Ferri L. Bernini M.G. Bongiorni Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis Arthritis Rheum 28 1985 1259
21. W.P. Follansbee The cardiovascular manifestations of systemic sclerosis (scleroderma) Curr Probl Cardiol 11 1986 242
22. W.P. Follansbee E.I. Curtiss T.A. Medsger Jr Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma N Engl J Med 310 1984 142
23. W.P. Follansbee E.I. Curtiss T.A. Medsger Jr Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma Am J Med 77 1984 489
24. W.P. Follansbee E.I. Curtiss P.S. Rahko The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature Am J Med 79 1985 183
25. W.P. Follansbee J.M. Kiernan E.I. Curtiss Cold-induced thallium perfusion abnormalities in diffuse scleroderma and Raynaud's disease: Response to diltiazem therapy Arthritis Rheum 30 suppl 1987 S117
26. W.P. Follansbee J.M. Kiernan E.I. Curtiss Left ventricular function during cold pressor stimulation in diffuse scleroderma, Raynaud's disease, and normals Arthritis Rheum 30 suppl 1987 S117
27. W.P. Follansbee T.R. Miller E.I. Curtiss A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma) J Rheumatol 17 1990 656
28. W.P. Follansbee T.R. Zerbe T.A. Medsger Jr Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): A high-risk association Am Heart J 125 1993 194
29. R. Frayha F. Jubran L. Partamian Hypertrophic nonobstructive cardiomyopathy in scleroderma Arthritis Rheum 21 1978 609
30. D.E. Furst P.J. Clements S. Hillis Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study Arthritis Rheum 32 1989 584
31. F.A. Gaffney R.J. Anderson J.V. Nixon Cardiovascular function in patients with progressive systemic sclerosis (scleroderma) Clin Cardiol 5 1982 569
32. A.J. Geirsson B. Blom-Bulow O. Pahlm Cardiac involvement in systemic sclerosis Semin Arthritis Rheum 19 1989 110
33. J.S. Gottdiener H.M. Moutsopoulos J.L. Decker Echocardiographic identification of cardiac abnormality in scleroderma and related disorders Am J Med 66 1979 391
34. R. Gustafsson F. Mannting E. Kazzam Cold-induced reversible myocardial ischemia in systemic sclerosis Lancet 2 1989 475
35. I. Hegedus L. Czirjak Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis Clin Rheumatol 14 1995 161
36. J. Heine Uber ein eigenartiges Krankheitsbild von diffuser Sklerosis der Haut and innerer Organe Virchows Arch 262 1926 351
37. B. Janevski Arteries of the hand in patients with scleroderma Diagn Imag Clin Med 55 1986 262
38. F. Jean A. Aubert F. Bloch Effects of diltiazem versus nifedipine on lower esophageal sphincter pressure in patients with progressive systemic sclerosis Arthritis Rheum 29 1986 1054
39. S.A. Jimenez S.H. Sigal A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine J Rheumatol 18 1991 1496
40. F. Joyal D. Choquette A. Roussin Evaluation of the severity of systemic sclerosis by nailfold capillary microscopy in 112 patients Angiology 43 1992 203
41. M.B. Kahaleh I. Osborn E.C. LeRoy Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma Ann Intern Med 96 1982 610
42. A. Kahan J.Y. Devaux B. Amor Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis N Engl J Med 314 1986 1397
43. A. Kahan J.Y. Devaux B. Amor Pharmacodynamic effect of dipyridamole on thallium-201 myocardial perfusion in progressive systemic sclerosis with diffuse scleroderma Ann Rheum Dis 45 1986 718
44. A. Kahan J. Devaux B. Amor Nicardipine improves myocardial perfusion in systemic sclerosis J Rheumatol 15 1988 1395
45. A. Kahan J. Devaux B. Amor The effect of captopril on thallium 201 myocardial perfusion in systemic sclerosis Clin Pharmacol Ther 47 1990 483
46. A. Kahan A. Nitenberg J. Foult Decreased coronary reserve in primary scleroderma myocardial disease Arthritis Rheum 28 1985 637
47. B. Kang C. Veres-Thorner R. Heredia Successful treatment of far-advanced progressive systemic sclerosis by D-penicillamine J Allergy Clin Immunol 69 1982 297
48. E. Kazzam A. Waldenstrom J. Landelius Noninvasive assessment of left ventricular diastolic function in patients with systemic sclerosis J Intern Med 228 1990 183 192
49. E. Kinney W. Reeves R. Zelis The echocardiogram in scleroderma: Endocarditis of the mitral valve Arch Intern Med 139 1979 1179
50. P.S. Klimiuk E.A. Kay M.L. Taylor Ketanserin: An effective treatment regimen for digital ischemia in systemic sclerosis Scand J Rheumatol 18 1989 107
51. Knop J, Bonsmann G: Cyclosporin in the treatment of progressive systemic sclerosis. In Schindler R (ed): First international symposium on cyclosporin in autoimmune disease. Basel, March 18-20, 1985, pp 199-200
52. J.B. Kostis J.R. Seibold D. Turkevich Prognostic importance of cardiac arrhythmias in systemic sclerosis Am J Med 84 1988 1007
53. E.V. Lally S.A. Jimenez S.R. Kaplan Progressive systemic sclerosis: Mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients Semin Arthritis Rheum 18 1988 1
54. P. Lee F.Y.-K. Leung C. Alderice Nailfold capillary microscopy in the connective tissue diseases: A semiquantitative assessment J Rheumatol 10 1983 930
55. I. Leinwand A.W. Duryee M.N. Richter Scleroderma (based upon a study of over 150 cases) Ann Intern Med 41 1954 1003
56. A. Long G. Duffy B. Bresnihan Reversible myocardial perfusion defects during cold challenge in scleroderma Br J Rheumatol 25 1986 158
57. H.R. Maricq E.C. LeRoy W.A. D'Angelo Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders Arthritis Rheum 23 1980 183
58. B.A. McGee M.D. Barnett R.E. Small Current options for the treatment of systemic sclerosis Clin Pharmacy 10 1991 14
59. J.E. McWhorter IV E.C. LeRoy Pericardial disease in scleroderma (systemic sclerosis) Am J Med 57 1974 566
60. T.A. Medsger Jr A.T. Masi Survival with scleroderma-II: A life-table analysis of clinical and demographic factors in 358 male US veteran patients J Chron Dis 26 1973 647
61. T.A. Medsger Jr G.P. Rodnan J. Moossy Skeletal muscle involvement in progressive systemic sclerosis (scleroderma) Arthritis Rheum 11 1968 554
62. P. Montanes C. Lawless C. Black The heart in scleroderma: A noninvasive assessment Clin Cardiol 5 1982 383
63. D.K. Moser W.G. Stevenson M.A. Woo Frequency of late potentials in systemic sclerosis Ann Cardiol 67 1991 541
64. M. Muers W. Stokes Treatment of scleroderma heart by D-penicillamine Br Heart J 38 1976 864
65. W.L. Norton E.R. Hurd D.C. Lewis Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: Quantitative study of the microvascular bed J Lab Clin Med 71 1968 919
66. K.A. Ntoso J.E. Tomaszewski S.A. Jimenez Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: Successful treatment of two patients and a review of the literature Am J Kidney Dis VIII 1986 159
67. S. Oram W. Stokes The heart in scleroderma Br Heart J 23 1961 225
68. N.K. Roberts W.R. Cabeen J. Moss The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis Ann Intern Med 94 1981 38
69. G.P. Rodnan R.L. Myerowitz G.O. Justh Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud's phenomenon Medicine (Baltimore) 59 1980 393
70. M.A. Sackner E.R. Heinz A.J. Steinberg The heart in scleroderma Am J Cardiol 17 1966 542
71. R. Salerni G.P. Rodnan D.F. Leon Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma) Ann Intern Med 86 1977 394
72. 2) receptor Arthritis Rheum 27 1984 139
73. R.J. Siegel B. O'Connor I. Mena Left ventricular function at rest and during Raynaud's phenomenon in patients with scleroderma Am Heart J 108 1984 1469
74. J.W. Smith P.J. Clements J. Levisman Echocardiographic features of progressive systemic sclerosis (PSS): Correlation with hemodynamic and postmortem studies Am J Med 66 1979 28
75. V.D. Steen S. Blair T.A. Medsger Jr The toxicity of D-penicillamine in systemic sclerosis Ann Intern Med 104 1986 699
76. V.D. Steen W.P. Follansbee Thallium perfusion abnormalities predict survival and cardiac dysfunction in patients with systemic sclerosis Arthritis Rheum 35 1992 S37
77. V.D. Steen T.A. Medsger Jr G.P. Rodnan D-penicillamine therapy in progressive systemic sclerosis (scleroderma): A retrospective analysis Ann Intern Med 97 1982 652
78. R.S. Surwit R.S. Gilgor L.M. Allen A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma Arch Dermatol 120 1984 329
79. J.M. Thompson R. Bluestone E.G.L. Bywaters Skeletal muscle involvement in systemic sclerosis Ann Rheum Dis 28 1969 281
80. G.S. Uhl G.M. Koppes Pericardial tamponade in systemic sclerosis (scleroderma) Br Heart J 42 1979 345
81. L. Urai G. Veress K. Urai Scleroderma—heart and conduction disturbances Acta Medica Academiae Scientiarum Hungaricae 35 1978 189
82. S. Weiss E.A. Stead Jr J.V. Warren Scleroderma heart disease, with a consideration of certain other visceral manifestations of scleroderma Arch Intern Med 71 1943 749
83. S.G. West P.J. Killian O.J. Lawless Association of myositis and myocarditis in progressive systemic sclerosis Arthritis Rheum 24 1981 662
84. C.F.O. Westphal Zwei Falle von schlerodermie Charite-Annalen (Berlin) 3 1876 341
85. D.E. Yocum R.L. Wilder Cyclosporin A in progressive systemic sclerosis Am J Med 83 1987 369
86. M.B. Yunus C.M. Radford A.T. Masi Aortic regurgitation in scleroderma J Rheumatol 11 1984 384
87. E.T. Zawada Jr P.J. Clements D.A. Furst Clinical course of patients with scleroderma renal crisis treated with captopril Nephron 27 1981 74